Refrigerated medicinal products, part 1: receipt and storage - some things to consider

Patient safety is the end objective for manufacturers, wholesalers, distributors and those healthcare professionals administering to patients. This blog is in 2 parts and draws on some of the findings from good distribution practice (GDP) inspections, references to the EU GDP …

Training matters

I have recently started as the Inspectorate’s learning and development manager. My background is in pharmacy, working in both community and hospital before joining the agency over 20 years ago. I can truthfully say I have enjoyed every minute here, …

PIC/S - Press release and news of MHRA chair in 2016/17

Back in October I attended, with MHRA colleagues, the PIC/S (Pharmaceutical Inspection Co-operation Scheme) committee meeting and annual seminar that was this year hosted by the Indonesian National Agency for Drug and Food Control (NADFC). In the new year I'll …

Helping us to help you – 5 top tips for making enquiries to the MHRA Inspectorate

The MHRA Inspectorate receives several hundred enquiries via email each year. Answering queries is one of the key ways we support industry. It provides reassurance to our stakeholders, aiding them in their decision-making processes, helping to ensure they don’t fall …

Your 'Pharmacy Show' questions answered by the MHRA GDP Inspectorate

Welcome to this, the next Inspectorate post.  My name is Madeleine Ault and I have been with MHRA for over 6 years now.  In that time I have inspected a wide range of wholesalers. These inspections cover large and small wholesalers, …

Supply of unlicensed medicines when an equivalent licensed product becomes available

blister pack

We've had a number of instances where licensed versions of commonly supplied unlicensed medicines have become available.  We want to remind stakeholders what to do if this happens. Recent examples of newly licensed products of this nature include fomicyt, 40mg/ml fosfomycin …